Bifogade filer
PDF
Kurs
+4,55%
Likviditet
0,08 MSEK
Kalender
| Tid* | ||
| 2025-02-26 | 08:30 | Bokslutskommuniké 2024 |
| 2024-11-26 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-29 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-10 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2024-05-08 | - | Årsstämma |
| 2024-05-08 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-27 | - | Bokslutskommuniké 2023 |
| 2023-11-09 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-29 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-10 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2023-05-09 | - | Årsstämma |
| 2023-05-09 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-27 | - | Bokslutskommuniké 2022 |
| 2022-11-09 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-29 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-03 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2022-05-02 | - | Årsstämma |
| 2022-05-02 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-28 | - | Bokslutskommuniké 2021 |
| 2021-11-09 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-24 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-12 | - | Årsstämma |
| 2021-05-05 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2021-05-03 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-19 | - | Extra Bolagsstämma 2021 |
| 2021-02-28 | - | Bokslutskommuniké 2020 |
| 2020-12-18 | - | Extra Bolagsstämma 2020 |
| 2020-11-09 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-24 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-23 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2020-06-22 | - | Årsstämma |
| 2020-05-04 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-25 | - | Bokslutskommuniké 2019 |
| 2019-11-18 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-26 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-07 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2019-05-06 | - | Årsstämma |
| 2019-05-06 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-26 | - | Bokslutskommuniké 2018 |
| 2018-08-27 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-08 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2018-05-07 | - | Årsstämma |
| 2018-02-27 | - | Bokslutskommuniké 2017 |
| 2017-09-25 | - | Extra Bolagsstämma 2017 |
| 2017-08-28 | - | Kvartalsrapport 2017-Q2 |
| 2017-04-06 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2017-04-05 | - | Årsstämma |
| 2017-02-22 | - | Bokslutskommuniké 2016 |
| 2016-10-26 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-25 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-09 | - | Årsstämma |
| 2016-05-09 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-23 | - | X-dag ordinarie utdelning REDS 0.00 SEK |
| 2016-02-22 | - | Bokslutskommuniké 2015 |
| 2015-11-27 | - | Kvartalsrapport 2015-Q3 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
OTCQX is a trading platform in the United States operated by the OTC Markets Group for securities not listed on a national stock exchange. The purpose of a cross-trading on OTCQX is to satisfy an increasing interest from US investors and to increase accessibility to the US capital market. Upon possible approval, Redsense Medical shares will be traded with a US ticker symbol and a share price in USD, in US market hours.
"Given that Redsense Medical has most of its revenue in the US, it is also natural that we initiate a process to facilitate for North American investors to trade in the Redsense Medical share. In addition, through a cross-trade on OTCQX, we make it easier for international investors and institutions who are considering having exposure to our shares. This initiative is in line with our increased focus on the US market in general and with a dual-quotation we will meet an increased interest in Redsense Medical", says Pontus Nobréus, CEO of Redsense Medical AB.
For more information, please contact:
Pontus Nobréus, CEO
Telephone: +46 72-171 1264
E-mail: pontus.nobreus (at) redsensemedical.com
Redsense Medical AB (publ), 556646-4862